Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMN76A4)

Drug Name

Anti-TLR3 mabs Drug Info

Synonyms

Anti-TLR3 mAbs (autoimmune and inflammatory disorders)

Indication

Disease Entry	ICD 11	Status	REF
Autoimmune diabetes	5A10	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Discontinued Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Toll-like receptor 3 (TLR3)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Rintatolimod	DMYX7VI	Human immunodeficiency virus infection	1C62	Phase 3	[2]
Poly-ICLC	DM2570B	Glioblastoma multiforme	2A00.0	Phase 2	[3]
BCG65-E7	DMAMFXC	Anal intraepithelial neoplasia	2E92.5	Discontinued in Phase 3	[4]
IPH-3102	DMY3BMC	Solid tumour/cancer	2A00-2F9Z	Terminated	[5]
polyIC	DMV486E	Discovery agent	N.A.	Investigative	[6]
Poly IC-poly arginine	DMXA4HY	Keratosis	ED56	Investigative	[1]
Poly-ICR	DMUMJ7B	Keratosis	ED56	Investigative	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1753).
2	A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. PLoS One. 2012;7(3):e31334.
3	Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models. J Transl Med. 2007 Feb 12;5:10.
4	Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia. Gynecol Oncol. 2010 Feb;116(2):208-12.
5	Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. Oncoimmunology. 2012 August 1; 1(5): 699-716.
6	Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001 Oct 18;413(6857):732-8.